These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21083440)

  • 1. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.
    Guerrero L; Pinazo MJ; Posada E; Gascón J; Ribas J; Soy D
    Clin Chem Lab Med; 2011 Jan; 49(1):77-82. PubMed ID: 21083440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
    Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and sensitive ultra-high-pressure liquid chromatography method for quantification of antichagasic benznidazole in plasma: application in a preclinical pharmacokinetic study.
    Davanço MG; de Campos ML; Peccinini RG
    Biomed Chromatogr; 2015 Jul; 29(7):1008-15. PubMed ID: 25424984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to
    Momper JD; Hanan NJ; Rossi SS; Mirochnick MH; Cafferata ML; Lavenia A; Flores I; Gibbons L; Ciganda A; Sosa Estani S; Capparelli EV; Buekens P
    Am J Trop Med Hyg; 2019 Jul; 101(1):116-122. PubMed ID: 31115303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.
    Marsón ME; Dana DD; Altcheh J; García-Bournissen F; Mastrantonio G
    J Clin Lab Anal; 2013 Sep; 27(5):384-90. PubMed ID: 24038224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue.
    Guerrero L; Martínez-Olondris P; Rigol M; Esperatti M; Esquinas C; Luque N; Piñer R; Torres A; Soy D
    Clin Chem Lab Med; 2010 Mar; 48(3):391-8. PubMed ID: 20113250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
    Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
    PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma.
    Padró JM; Marsón ME; Mastrantonio GE; Altcheh J; García-Bournissen F; Reta M
    Talanta; 2013 Mar; 107():95-102. PubMed ID: 23598198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
    Carrilero B; Murcia L; Martínez-Lage L; Segovia M
    Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results.
    Richle RW; Raaflaub J
    Acta Trop; 1980 Sep; 37(3):257-61. PubMed ID: 6106364
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials.
    Molina I; Salvador F; Sánchez-Montalvá A; Artaza MA; Moreno R; Perin L; Esquisabel A; Pinto L; Pedraz JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
    Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
    Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis and benznidazole: more closely related than we thought.
    Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study.
    Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS
    Rev Soc Bras Med Trop; 2013; 46(6):776-8. PubMed ID: 24474023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
    Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
    Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
    Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.
    Moreira da Silva R; Oliveira LT; Silva Barcellos NM; de Souza J; de Lana M
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3344-8. PubMed ID: 22450981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benznidazole prevents endothelial damage in an experimental model of Chagas disease.
    Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Leiva M; Ferreira J; López-Muñoz R; Maya JD
    Acta Trop; 2013 Jul; 127(1):6-13. PubMed ID: 23529066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.